#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn't enough, and the future of psychedelic therapies | Linus Abrams, M.D.

Episode Summary

Executive Summary: This episode argues that psychiatry should move beyond symptom suppression toward restoring human functioning by integrating psychopharmacology with endocrinology, sleep, metabolism, inflammation, and stress physiology. Dr. Abrams explains how SSRIs/SNRIs, bipolar diagnosis, thyroid and sex hormones, and emerging ketamine/psychedelic therapies fit into a broader, whole-body model of mental health.

Main Topics: Psychiatry’s goal: symptom reduction vs restoring lived experience (Priority: 5/5): Abrams argues modern psychiatry often succeeds at reducing symptoms but fails to restore vitality, agency, and quality of life. He frames his work as humanistic psychiatry plus psychopharmacology, and emphasizes psychotherapy and individualized diagnosis. Antidepressants, SSRIs/SNRIs, and diagnostic nuance (Priority: 5/5): The discussion covers monoamine biology, why SSRIs can help anxiety and depression yet blunt dopamine/norepinephrine-driven energy, and why SSRI/SNRI selection depends on symptom profile. They also discuss older drugs like MAOIs and tricyclics and their limitations. Bipolar vs unipolar depression (Priority: 5/5): A major theme is the clinical importance of distinguishing bipolar depression from unipolar depression, because antidepressants can worsen bipolar illness by triggering hypomania, cycling, or mixed states. Mood stabilizers such as lithium and lamotrigine are emphasized. Hormones as brain regulators (Priority: 5/5): Abrams details how estradiol, testosterone, progesterone, and thyroid hormone modulate neurotransmission, neuroplasticity, and mood. He argues endocrinology is underappreciated in psychiatry and that hormone shifts can meaningfully alter cognition, libido, mood, and resilience. Modernity, stress physiology, sleep, and mental health (Priority: 4/5): The conversation links rising depression/anxiety to social media, isolation, socioeconomic comparison, disrupted sleep/circadian rhythms, chronic stress, poor nutrition, and metabolic dysfunction. Modern environments are portrayed as anti-normative to ancient biology. Ketamine and psychedelic therapies (Priority: 4/5): They discuss ketamine as a rapid-acting but temporary bridge for severe depression/suicidality, and psychedelics as potentially transformative but unpredictable tools. Both speakers stress therapeutic promise alongside real risks and the need for careful supervision. Postpartum, menopause, and perimenopausal psychiatric presentations (Priority: 4/5): Specific endocrine transitions are explored, including postpartum hormone withdrawal, PMDD, menopause, and how these can unmask latent mood disorders. Treatment examples include xuranolone for acute postpartum depression and lamotrigine for overlooked bipolarity.

Key Arguments: Psychiatry should not only reduce symptoms; it should aim to restore the full human experience and functioning. SSRIs are often better understood as anti-anxiety medications than as simple antidepressants, and they may blunt dopamine/norepinephrine-related vitality. Correctly distinguishing bipolar depression from unipolar depression is essential because antidepressants can destabilize bipolar patients. Estradiol is a major neuromodulator in the brain, affecting serotonin, dopamine, GABA, glutamate, acetylcholine, and gene transcription. Testosterone and estradiol deficiencies in men and women can present as mood, cognition, libido, and motivation problems, not just reproductive issues. Thyroid labs should be interpreted beyond TSH alone; low-normal free T4/free T3 can still be clinically relevant in depressed patients. Cortisol/hyperarousal is often a downstream signal of stress load rather than the primary problem, so treatment should focus on source stressors. Modernity likely worsens mental health by increasing isolation, comparison, digital overload, and circadian disruption. Ketamine can rapidly reduce suicidality and severe depressive symptoms, but its effects may be short-lived and unpredictable. Classic psychedelics may produce durable change through neuroplasticity and belief revision, but reactions can be profoundly positive or negative.

Data Points: Clinical experience: Nearly 35 years - Dr. Abrams’ psychiatry practice and psychopharmacology background Harvard residency focus: Psychotherapy and psychopharmacology - He intentionally chose training that combined both modalities Bipolar spectrum experience: About one-third - He estimates roughly one-third of his patients have been highly successful people with hypomanic drive Severe postpartum depression/psychosis prevalence: Less than 1% - He describes the most dramatic acute postpartum presentations as rare Estradiol in women vs testosterone: ~10x higher testosterone than estradiol in women when normalized - He explains lab units differ (ng/dL vs pg/dL), so raw numbers are misleading Postpartum estradiol drop: ~30,000 to ~30 - He describes a dramatic postpartum fall in estradiol within 24–48 hours Postpartum progesterone drop: Several hundred to less than 1 - He describes the abrupt postpartum fall in progesterone within 24–48 hours Typical duration after an acute depressive episode: 8 to 12 months - He cites evidence-based maintenance duration before tapering after response T3 starting dose: 2.5 mcg twice daily - He starts low when using liothyronine for depression T3 higher-end dose: 25 mcg twice daily - He notes some depressed patients respond at this level with normal vitals Ketamine treatment frequency: Up to 3+ times/week - He says some infusion centers may administer it this often in severe cases Psychedelic dose example: 5 grams - He refers to a case report of psilocybin given at a full therapeutic dose His own psilocybin experience: >10 grams - He reports needing more than standard doses due to high medication resistance Duration of his own positive psychedelic effect: ~10 years - He believes one psilocybin experience produced a lasting gratitude/empathy shift

Pivotal Quotes: "psychiatry aims at reduction of symptoms, but not restoration of the full human experience that makes life most worthwhile" — Dr. Linus Abrams: His core critique of conventional psychiatry "estradiol is a constitutive pleiotropic multi-system regulator of neurotransmitters and neural circuits" — Dr. Linus Abrams: His explanation of why sex hormones matter in psychiatry "The cortisol is a signal... it’s not really the primary problem, it’s a secondary manifestation of a primary stress problem" — Dr. Linus Abrams: His view that stress physiology points to upstream life and environment factors

Implications: Listeners should think of mental health as whole-body physiology, not just neurotransmitters. For clinicians, better diagnosis and endocrine/sleep/stress assessment may improve outcomes. For the field, hormone- and neuroplasticity-based therapies may expand—but require caution and better evidence.